NetworkNewsBreaks

MondayFeb 01, 2021 9:00 am

NetworkNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) CEO Participates in Online TD Securities Mining Conference

Uranium Energy (NYSE American: UEC) president and CEO Amir Adnani was a participant in the virtual TD Securities Mining Conference held Jan. 28, 2021. As part of his participation, Adnan was featured in a live webcast that started at 3:20 p.m. ET. The presentation was recorded and is available on the company’s website for all interested viewers. Headquartered in South Texas, UCE is a U.S.-based uranium mining and exploration company with projects Texas, Wyoming, Arizona, New Mexico, Colorado and Paraguay. Its Reno Creek Project in Wyoming is the largest permitted, preconstruction in-situ recovery (“ISR”) uranium project in the United States.…

Continue Reading

FridayJan 29, 2021 3:10 pm

NetworkNewsBreaks – United Medical Equipment Business Solutions Network Inc. Poised Across Continuum of Health Care

United Medical Equipment (“UME,” “UMEBSNI”) continues to address unique testing needs created by the ongoing global pandemic. As part of the company’s efforts to provide essential services during the epidemic, UMEBSNI is a trusted supplier of FDA-approved COVID-19 rapid antigen test kits that detect coronavirus antibodies that appear in the bloodstream of infected individuals within 10 minutes. The test can also indicate whether a person has protection against the coronavirus. In addition, UMEBSNI offers a unique mobile solution with testing specialists and experienced medical staff members providing onsite COVID-19 Rapid Testing and solutions to implement employee safety. These on-call mobile…

Continue Reading

FridayJan 29, 2021 2:56 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) Poised to Provide Breakthrough Therapy for MDD

Cybin (NEO: CYBN), a mushroom life science company, is at the forefront of new treatments targeting major depressive disorder (“MDD”). The company is working to become the first to bring a psilocybin drug to market that targets MDD. This positions Cybin to provide solutions amid significant demand, with more than 18 million people in the United States and 300 million people worldwide who experience major depression according to the National Institute of Mental Health. A recent article discussing this reads, “Since 2018, the FDA has labeled psychedelic psilocybin a ‘breakthrough therapy’ to treat MDD. This designation fast tracks the substance…

Continue Reading

FridayJan 29, 2021 2:41 pm

NetworkNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Announces Promising Results from CyberAgrot Study

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an innovative agriculture biotech company focused on providing natural biological protection for high value crops, recently released potentially industry-changing results for its initial Colombia laboratory test. The study evaluated the effect of its proprietary mustard-derived organic biopesticide formulation on the disease Fusarium wilt TR4. MustGrow’s study, conducted and reported via third-party laboratory CyberAgrot SAS in Colombia using Instituto Colombiano Agropecuario (“ICA”) official protocols, reported 100% control of the disease. A recent article discussing this reads, “In the announcement, MustGrow outlined the CyberAgrot study results. Carefully adhering to ICA official protocols, the test evaluated…

Continue Reading

FridayJan 29, 2021 2:24 pm

NetworkNewsBreaks – CannAssist International Corporation (CNSC) Leverages Proprietary Technology to Stand Distinct in Surging Market

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, rapidly garnered a reputation and loyal following due to its innovative technology and proprietary product line, marketed through its Xceptol consumer brand. The company was founded in May 2017 and moved to the forefront of the cannabidiol industry following the passing of the 2018 Farm Bill, whereby the United States effectively decriminalized the cultivation and use of hemp and its derivative products. The global cannabidiol (“CBD”) industry has since surged to new heights, set to rise from a market value of $4.6 billion in 2018 to an estimated $23.6 billion by…

Continue Reading

FridayJan 29, 2021 1:45 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Enters Strategic Partnership to Reestablish US REE Production

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, is positioned in what could be called a milestone moment in re-establishing a fully integrated rare earth element (“REE”) supply chain in the United States. The company recently announced a three-year supply agreement with the Chemours Company (NYSE: CC), under which it will receive a minimum of 2,500 tons of natural monazite ore per year, one of the highest-grade rare earth element (“REE”) minerals in the world. Energy Fuels will process this monazite at its 100%-owned White Mesa Mill in Southeast Utah to produce a marketable mixed…

Continue Reading

FridayJan 29, 2021 1:18 pm

NetworkNewsBreaks – Gage Cannabis Co. Secures $50M in Reg A, Tier 2 Offering

Gage Cannabis, the leading high-quality craft cannabis brand in Michigan, has announced the final closing of its Regulation A, Tier 2, equity financing (the “offering”). In total, Gage secured gross proceeds of US$50,000,000, the maximum amount qualified under the company’s offering circular, through the issuance of 28,571,400 subordinate voting shares. The oversubscribed offering included institutional and retail investor demand and significantly expanded the Gage’s ownership base through the addition of over 1,000 new shareholders. “We are humbled and excited by the significant interest and investor demand we received for our oversubscribed Reg A financing,” said Fabian Monaco, president of Gage.…

Continue Reading

FridayJan 29, 2021 1:03 pm

NetworkNewsBreaks – ev Transportation Services Inc.’s New ESV Designed to Meet Needs of Essential Services Transportation, Urban Mobility Sectors

ev Transportation Services (“evTS”), a designer, developer and manufacturer of all-electric lightweight commercial vehicles and fleet management solutions, recently announced the launch of its new 2021 FireFly ESV. The EV was created to meet the requirements of the essential services transportation and urban mobility markets, with estimated replacement demand of 100,000, equaling approximately $2.5 billion annually. A recent article discussing this reads, “Designed for efficiency and performance, the Firefly has a range of 100-plus miles on a single charge and can legally travel on all roads at speeds up to 50 miles per hour. This exceeds the capabilities of other…

Continue Reading

FridayJan 29, 2021 10:43 am

NetworkNewsBreaks – SRAX (NASDAQ: SRAX) Served as Exclusive Tech Host for B. Riley Event

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (”SaaS”) platform, served as technology host for B. Riley Securities’ 2021 Vision Day held on Jan. 28, 2021. SRAX was the exclusive tech host for the event, which was held on its proprietary Sequire Virtual Events platform. B. Riley Securities’ 2021 Vision Day was a daylong virtual investor conference. The conference agenda included multiple video presentations and fireside chats that focused on top stock picks of B. Riley’s award-winning equity research team. B. Riley clients and investors accessed the live on…

Continue Reading

FridayJan 29, 2021 10:31 am

NetworkNewsBreaks – Applied DNA Sciences Inc. (NASDAQ: APDN) Has Closed Registered Direct Offering Resulting in $15M

Applied DNA Sciences (NASDAQ: APDN) (OTC: APPDW), a leader in polymerase chain reaction (“PCR”)-based DNA manufacturing, announced that it has officially closed the registered direct offering of 1,810,000 shares of common stock. The shares were sold at $8.30 per share, resulting in a total of $15 million for the company. APDN provides molecular technologies that enable supply chain security. The company also offers anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates. Sole placement agent for the offering was Roth Capital Partners. To view the full press release, visit https://www.nnw.fm/N2ah4 About Applied DNA Sciences Applied DNA…

Continue Reading